APOE genotype effects on alzheimer’s disease onset and epidemiology
The risk of developing Alzheimer’s disease (AD) is tied most closely to age and appears to follow Gompertzian kinetics. However, specific genetic factors are also linked closely to AD, and the apolipoprotein E (APOE) genotype accounts for as much of 50% of the attributable risk for AD in many populations. This paper reviews the onset, diagnosis, and epidemiology of AD, specifically with regard to the APOE genotype and the interaction of the genotype with age.
Index EntriesAlzheimer’s disease dementia genetics apolipoprotein E Gompertz aging epidemiology
Unable to display preview. Download preview PDF.
- Ashford J. W., Kindy M. S., Shih W.-J., Cool C., Aleem B., Cobb L., et al. Clinical onset of Alzheimer’s disease (AD) is earlier in patients with an APOE ε4 allele. Annual Meeting, Society for Neuroscience, Orlando, FL, 723.4, 2002.Google Scholar
- Ashford J. W. and Mortimer J. A. (2002) Non-familial Alzheimer’s disease is mainly due to genetic factors. J. Alzheimer’s Dis. 4, 169–177.Google Scholar
- Ashford J. W., Schmitt F., and Kumar V. (1998a) Diagnosis of Alzheimer’s disease, in Advances in the Diagnosis and Treatment of Alzheimer’s Disease, Kumar, V., and Eisdorfer, C., eds., Springer, New York, pp. 111–151.Google Scholar
- Ashford J. W., Mattson M., and Kumar V. (1998b) Neurobiological systems disrupted by Alzheimer’s disease and molecular neurobiological theories of vulnerability, in Advances in the Diagnosis and Treatment of Alzheimer’s Disease, Kumar, V., and Eisdorfer, C., eds., Springer, New York, pp. 53–89.Google Scholar
- Ashford J. W., Shih W.-J., Coupal J., Shetty R., Schneider A., Cool C., et al. (2000) Single SPECT measures of cerebral cortical perfusion reflect “Time-Index” estimation of dementia severity in Alzheimer’s disease. J. Nuclear Med. 41, 57–64.Google Scholar
- Codemo A., Corti M. C., Mazzetto G., Varotto S., Cortella I., Crepaldi G., and Gabelli C. (2000) Education, APOE status and cognitive impairment in the elderly: an epidemiological study in a rural setting. Neurobiol. Aging 21, S246.Google Scholar
- Guo Z., Fratiglioni L., Viitanen M., Lannfelt L., Basun, H., Fastbom J., and Winblad B. (2001) Apolipoprotein E genotypes and the incidence of Alzheimer’s disease among persons aged 75 years and older: variation by use of anti-hypertensive medication? Am. J. Epidemiol. 153, 225–231.PubMedCrossRefGoogle Scholar
- Koudinov A. R. and Koudinova N. V. (2001) Essential role for cholesterol in synaptic plasticity and neuronal degeneration. FASEB J. 10, 1858–1869.Google Scholar
- Oppenheimer S. (2003) The Real Eve: Modern Man’s Journey Out of Africa. Carroll and Graf Publishers, New York.Google Scholar
- Sacher G. A. (1977) Life table modification and life prolongation, in The Handbook of the Biology of Aging, Finch, C. E., and Hayflick, L., eds., Van Nostrand Reinhold, New York, pp. 582–638.Google Scholar
- Strehler B. L. (1977) Time, Cells, and Aging, Academic Press, New York.Google Scholar
- Winnock M., Letenneur L., Jacqmin-Gadda H., Dallongeville J., Amouyel P., and Dartigues J. F. (2002) Longitudinal analysis of the effect of apolipoprotein E ε4 and education on cognitive performance in elderly subjects: the PAQUID study. J. Neurol. Neurosurg. Psychiatry. 72, 794–797.PubMedCrossRefGoogle Scholar